This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (204) Protocols for Public Health Research and Surveillance (114) Complementary and Alternative Medicine (103) Methods and Instruments in Medical Informatics (199) Chronic Conditions (451)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/82633, first published .
Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post–COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial

Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post–COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial

Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post–COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial

Authors of this article:

Yunqing Xun1 Author Orcid Image ;   Tung Leong Fong1 Author Orcid Image ;   Guang Chen1 Author Orcid Image ;   Yibin Feng1 Author Orcid Image ;   Linda Chan1, 2, 3, 4 Author Orcid Image ;   Ning Wang1 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.